SEC Form 4 · accession 0001209191-15-035355
ZEVRA THERAPEUTICS, INC. · ZVRA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Sven Guenther
Officer — Exec VP R&D
Period of report
Apr 21, 2015
Accepted (ET)
Apr 21, 2015 · 6:45 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001434647
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | Apr 21, 2015 | C | 23,852 | — | A | 43,852 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Series A Convertible Preferred StockF2 | — | Apr 21, 2015 | C | 26,355 | D | — | — | Common Stock | 3,514 | 0 | D |
| Series B Convertible Preferred StockF2 | — | Apr 21, 2015 | C | 16,129 | D | — | — | Common Stock | 2,150 | 0 | D |
| Series C Convertible Preferred StockF2 | — | Apr 21, 2015 | C | 136,410 | D | — | — | Common Stock | 18,188 | 0 | D |
Explanation of responses
- F1The total represents shares received upon conversion of Series A, Series B and Series C convertible preferred stock.
- F2Effective upon the closing of the Issuer's initial public offering of its common stock, each share of Series A, Series B and Series C convertible preferred stock automatically converted into 0.13333 shares of common stock. The convertible preferred stock had no expiration date.